|
|
|
When it comes to health care, we men are like ostriches. Yet it’s obviously important that men of all ages become more proactive about their health. As a result, they rapidly drive up blood sugar levels, which contributes to...
Mark Henderson, Science Editor A nanotechnology therapy that targets cancer with a “stealth smart bomb” is to begin patient trials next year in the first clinical test of a pioneering approach to medicine, The Times has learnt....
Astellas Pharma Inc. of Japan and California's Medivation Inc. have announced a global agreement to develop and commercialize MDV3100, a chemical compound developed in UCLA science laboratories that is now Medivation's...
In a press release issued November 3, 2009, Bodybuilding.com LLC, an online supplement retailer, announced that it was conducting a voluntary recall of 65 dietary supplements that were sold through th read more
The reality is that testicular cancer is a young man_s disease with most cases occurring in men aged 15 to 40. Such is the case for testicular cancer, a rare but highly treatable cancer in men. Surgery causes testicular cancer...
EUSA Pharma announced that PROSTASCINT® (capromab pendetide) fusion imaging was shown to effectively guide prostate cancer therapy targeting and dosing and is a significant predictor of disease free survival, according to data...
LYON, France, Nov. 4, 2009 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today details relating to its third quarter 2009 earnings announcement, which will take place on...
SEOUL, Korea, Nov. 4 /PRNewswire/ -- Dong-A PharmTech Co. Ltd., announced that its U.S. partner, Warner Chilcott plc, has initiated two, phase III trials for udenafil, a new long acting drug under development for erectile...
The Associated Press Date: Wednesday Nov. 4, 2009 8:49 AM ET MILWAUKEE — Men may protect more than their hearts if they keep cholesterol in line: Their chances of getting aggressive prostate cancer may be lower, new research...
Current study results from the report, 'The impact of the 2005 International Society of Urological Pathology (ISUP) consensus on Gleason grading in contemporary practice,' have been published. In this recent study, researchers...
